Control Group:Feilike capsule+Shiwei Longdanhua capsule analog agent

2 trials

Sponsors

The Second Affiliated Hospital of Tianjin University of Chinese Medicine

Conditions

Acute exacerbation of chronic bronchitisAcute tracheobronchitis

Phase 4

To evaluate the efficacy, safety and pharmacoeconomics of Shiwei Longdanhua capsule in the treatment of acute exacerbation of chronic bronchitis (phlegm-heat obstructing lung syndrome)

RecruitingChiCTR2200066665

The Second Affiliated Hospital of Tianjin University of Chinese MedicineAcute exacerbation of chronic bronchitis

Start: 2022-12-16Updated: 2023-05-15

To evaluate the efficacy, safety and pharmacoeconomics of Shiwei Longdanhua capsule in the treatment of acute tracheo-bronchitis (phlegm-heat obstructing lung syndrome)

RecruitingITMCTR2200006863

The Second Affiliated Hospital of Tianjin University of Chinese MedicineAcute tracheobronchitis

Start: 2022-12-16Updated: 2023-03-06

Related Papers

Efficacy, Safety, and Pharmacoeconomic Evaluation of Shiwei Longdanhua Capsules in Acute Exacerbation of Chronic Bronchitis with Phlegm-Heat Obstructing Fei (Lung): A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Control Trial.

2026-09-16